Morikawa K, Walker S M, Jessup J M, Fidler I J
Department of Cell Biology, University of Texas M.D. Anderson Hospital and Tumor Institute at Houston 77030.
Cancer Res. 1988 Apr 1;48(7):1943-8.
The purpose of these studies was to select and isolate cells with increased liver-metastasizing potential from heterogeneous primary human colon carcinomas (HCCs). Cells derived from a primary HCC classified as Dukes' stage B2 were directly established in culture or were injected into the subcutis, cecum, or spleen of nude mice. Progressively growing tumors were excised, dissociated, and established in culture. Subsequent to implantation into the cecum or spleen of nude mice, cells from all four lines produced only a few liver tumor foci. HCC cells from the few liver metastases were expanded in culture and then injected into the spleen of nude mice to provide a source for further cycles of selection. With each successive in vivo selection cycle, the metastatic ability of the isolated propagated cells increased. Four cycles of selection yielded cell lines with a very high metastatic efficiency in nude mice. In parallel studies using another primary HCC classified as Dukes' stage D, we isolated cell lines that were highly metastatic in nude mice. Successive selection cycles for growth in the liver increased the metastatic properties of the HCC cells, albeit to a lesser extent than it did those of the Dukes' B2 stage HCC. The ability of the HCC cells to produce liver metastases was not due to simple trapping in the liver. In vivo distribution studies using [125I] iododeoxyuridine-labeled tumor cells revealed that, shortly after injection into the spleen, a comparable number of cells with either low or high metastatic properties arrested in the liver. The differences between the low- and high-degree metastatic cells became apparent by 24 h after injection and, by 72 h, only highly metastatic cells survived in the liver. These results demonstrate that hepatic metastasis by HCC cells is a selective process and that the nude mouse model can be useful for isolating highly metastatic HCC cells and for studying the relevant host organ factors that regulate the pathogenesis of metastasis.
这些研究的目的是从异质性原发性人类结肠癌(HCC)中筛选并分离出具有更高肝转移潜能的细胞。从一例被分类为Dukes B2期的原发性HCC中获取的细胞,直接进行培养,或将其注射到裸鼠的皮下、盲肠或脾脏中。将逐渐生长的肿瘤切除、解离并进行培养。在植入裸鼠的盲肠或脾脏后,来自所有四个细胞系的细胞仅产生了少数肝肿瘤灶。从少数肝转移灶中获取的HCC细胞在培养中扩增,然后注射到裸鼠的脾脏中,以提供进一步筛选周期的来源。随着每个连续的体内筛选周期,分离出的增殖细胞的转移能力增强。经过四个筛选周期,获得了在裸鼠中具有非常高转移效率的细胞系。在使用另一例被分类为Dukes D期的原发性HCC进行的平行研究中,我们分离出了在裸鼠中具有高转移性的细胞系。在肝脏中连续进行生长筛选周期增加了HCC细胞的转移特性,尽管程度低于Dukes B2期HCC细胞。HCC细胞产生肝转移的能力并非简单地由于在肝脏中滞留。使用[125I]碘脱氧尿苷标记的肿瘤细胞进行的体内分布研究表明,注射到脾脏后不久,具有低转移或高转移特性的相当数量的细胞在肝脏中滞留。低转移和高转移细胞之间的差异在注射后24小时变得明显,到72小时时,只有高转移细胞在肝脏中存活。这些结果表明,HCC细胞的肝转移是一个选择性过程,并且裸鼠模型可用于分离高转移性HCC细胞以及研究调节转移发病机制的相关宿主器官因素。